News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Denali Therapeutics Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Deals
Ex-Genentech Employees’ Denali Breaks 2017 IPO Records, Raises $250M
With the raise, the company’s market valuation is currently $1.7B.
December 8, 2017
·
2 min read
·
Mark Terry
Deals
Run by Former Genentech Employees, Bay Area’s Denali Seeks $100M IPO
Denali plans to make a $100M IPO under the symbol DNLI.
November 14, 2017
·
2 min read
·
Mark Terry
Business
The Next Generation: Top 20 Life Science Startups to Watch in 2017
BioSpace is proud to present its NextGen “Class of 2017,” which is a list of 20 up-and-coming life science companies that launched no earlier than 2014.
January 3, 2017
·
11 min read
·
Mark Terry
Business
What You Need to Know About Denali
January 3, 2017
·
4 min read
Business
Led by Former Genentech Execs, Denali Banks $130 Million, Initiates Trial and Announces a Handful of Partnerships
August 25, 2016
·
3 min read
Biotech Bay
Nine Bay Area Biotechs Vie to be the “Next Genentech”
May 24, 2016
·
4 min read
Business
Inside the $50 Billion Biotech Sugar Daddy that Invested in Startups Like Denali, Juno
March 3, 2016
·
3 min read
Job Trends
Denali, Helmed by Former Genentech Execs, Takes Space in South San Francisco Site
January 18, 2016
·
2 min read
Business
Pfizer Board Member Jumps Ship to $217 Million Startup Denali
May 21, 2015
·
3 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Denali Therapeutics Announces Key Anticipated Milestones and Priorities for 2026 Including Commercial Launch of Tividenofusp Alfa for Hunter Syndrome
January 6, 2026
·
10 min read
Press Releases
The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics’ Tividenofusp Alfa (DNL310) for Hunter Syndrome (MPS II)
December 30, 2025
·
12 min read
Press Releases
Denali Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
December 10, 2025
·
4 min read
Press Releases
Denali Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants
December 10, 2025
·
3 min read
Press Releases
Denali Therapeutics and Royalty Pharma Announce $275 Million Royalty Funding Agreement
December 4, 2025
·
8 min read
Press Releases
Denali Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights
November 6, 2025
·
13 min read
Press Releases
Denali Therapeutics Announces Board and Executive Leadership Updates
November 6, 2025
·
7 min read
Press Releases
Denali Therapeutics Announces FDA Review Extension of BLA for Tividenofusp Alfa for the Treatment of MPS II (Hunter Syndrome)
October 14, 2025
·
6 min read
Press Releases
Denali Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights
August 12, 2025
·
12 min read
Press Releases
Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)
July 8, 2025
·
8 min read
